Grad School Alumni News

Researchers Awarded $1 Million to Study Optimal Use of Radioactive Drugs for Prostate Cancer Therapy

Dr. Scott Tagawa. Photo credit: Walling McGarity

Researchers at Weill Cornell Medicine, in collaboration with investigators at Dana-Farber Cancer Institute, have been awarded a three-year, $1 million grant from the U.S. Department of Defense (DoD) for prostate cancer clinical trials.

Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer death in men. The DoD’s Prostate Cancer Research Program Clinical Consortium...

A Kinder Cut

Dr. Alexander Perez. Photo credit: John Abbott

In 2013, scientists at MIT and at UC Berkeley optimized a way to use bacterial gene sequences to cut and change DNA at precise locations. The genome-editing system, called CRISPR, is cheaper and simpler than previous methods, and it has led to breakthroughs in diagnostics and the creation of more accurate disease models. And because it can permanently modify a living organism’s DNA, CRISPR technology may one day allow physicians to treat genetic diseases—anything from congenital deafness to...

Risk of Cardiovascular Event Jumps Significantly Before Cancer Diagnosis

Dr. Babak Navi

Older adults with cancer are nearly 70 percent more likely to suffer a stroke or heart attack in the year prior to their diagnosis compared with peers without a cancer diagnosis in that same time period, according to new research by Weill Cornell Medicine, NewYork-Presbyterian and Memorial Sloan Kettering Cancer Center investigators.

The paper, published Dec. 21 in the...

Office of Alumni Relations 1300 York Avenue, Box 61 New York, NY 10065 Phone: 646-962-9560